Articles tagged with Stem Cell Therapy
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers discovered that cell shape influences stem-cell fate, with star shapes promoting bone formation and flower shapes promoting fat production. The study offers a promising direction for further investigation into stem-cell therapies.
A software program created by Andrew Cohen analyzes time-lapse images to identify changes in cell behaviors, predicting the types of specialized cells a stem cell will produce. The software is 87% accurate in determining specific 'offspring' a stem cell will ultimately produce, and 99% accurate in predicting when self-renewal will end ...
Researchers demonstrate that transplanted stem cells can rescue diseased neurons from death by sending signals through gap junctions, a newly recognized way of cell communication. This mechanism may play a role in both normal development and many diseases, including Huntington's disease and spinal cord injuries.
A study published in PNAS found that delivering stem cells on a polymer scaffold to treat large areas of missing bone leads to improved bone formation. However, the therapeutic effect is limited by the migration of stem cells away from the injury site, highlighting the need for improved delivery methods.
Chinese researchers have become a leading contributor to peer-reviewed scientific literature on clock-reversing regenerative medicine, with over 1,100 publications in 2008. New regulations aim to improve patient safety and restore China's global reputation.
Researchers at the University of Pittsburgh School of Medicine have found that umbilical cord tissue contains a plentiful supply of stem cells that could be used to treat various muscle and bone disorders. The study reveals that these cells can be easily harvested from the tissue, expanded in number, and are remarkably stable.
Researchers at the North East England Stem Cell Institute have developed a successful stem cell therapy to treat Limbal Stem Cell Deficiency (LSCD), a painful and blinding disease. The treatment, which uses patients' own stem cells without immunosuppression, shows promise for restoring sight in hundreds of people.
Researchers at UT Houston are conducting a Phase II trial using adult human mesenchymal stem cells to treat acute heart attacks. The study shows promising results, with patients experiencing fewer arrhythmias and improved overall condition after receiving the treatment.
Researchers at Helmholtz Munich have discovered a new source of nerve cell generation in the adult brain, specifically in the olfactory bulb. This discovery may lead to new therapeutic approaches for Alzheimer's disease, where nerve cell degeneration plays a crucial role.
Researchers found that transplanted human-derived umbilical cord blood stem cells had positive therapeutic effects on specific lung and heart disorders in animal models. The study showed that MSCs have anti-inflammatory effects and can differentiate into various cell types, including lung-specific cells.
Researchers have successfully generated human epidermis from human embryonic stem cells, providing a potential unlimited resource for temporary skin replacement in patients with large burns. The skin substitute was shown to be functional and structurally consistent with human skin after just 12 weeks of grafting onto mice.
Researchers have successfully used a gene therapy technique to slow the onset of X-linked adrenoleukodystrophy, a severe brain disease, in two patients. The treatment involved introducing a therapeutic gene into blood cells using a lentiviral vector, which showed promise in slowing disease progression and improving neurological function.
Researchers have achieved significant success with gene therapy in treating adrenoleukodystrophy (ALD), a potentially fatal brain disorder. The treatment has arrested the progression of the disease in two boys, showing no adverse effects to date.
Researchers have identified a molecular mechanism underlying DES-induced male infertility in mice, which may be linked to increased incidence of human reproductive disorders. The study found that neonatal exposure to DES disrupts the protein NR0B2, leading to reduced fertility and protected males against negative effects.
Researchers genetically engineered adult neural stem cells to express anti-inflammatory molecule IL-10, improving functional and pathological recovery from multiple sclerosis. These modified cells induced immunomodulation, nerve cell repair, and production of the nerve cell protective sheath.
Scientists at Gladstone Institute of Cardiovascular Disease and Stanford University School of Medicine are developing induced pluripotent stem cells to repair damaged heart muscle. The $10 million, 7-year project aims to identify and characterize progenitor cell lines and develop new clinical strategies for regenerative therapies.
Adult stem cells from bone marrow have shown promise in preventing and treating acute lung injury by repairing damaged endothelial cells. Researchers found that these progenitor stem cells, named Flk-1 and CD34, can repair lung damage and improve survival when administered to mice with ALI.
Physician-researchers at USC have received a nearly $16 million grant to develop a stem cell-based treatment for age-related macular degeneration. The four-year study aims to replace damaged retinal cells with healthy ones derived from human embryonic stem cells.
Researchers have tested various cell-based therapies in mice with Alport syndrome, a genetic kidney disease. Stem cell treatments may repair kidney defects associated with the disease, offering promise for patients.
Scripps Research scientists successfully corrected a genetic defect in mice with cystinosis, a rare and devastating disorder. The treatment involved bone marrow stem cell transplantation, which significantly reduced cystine levels and improved symptoms.
The 2009 Lasker Awards honor pioneering work in cancer and stem cell research, promising new therapies and a $700 million global market. Renowned scientists receive awards for their discoveries in nuclear reprogramming techniques and regenerative medicine.
Researchers at Tel Aviv University have successfully tracked bone marrow stem cells as they repair damaged brain tissue in a live animal model of Huntington's disease. The innovative use of MRI tracking enables the monitoring of cell viability and migration towards diseased areas, paving the way for potential therapy.
A team of researchers has identified phosphorylated signaling proteins in human embryonic stem cells, shedding light on the mechanisms that determine cell fate. The study's findings may lead to the development of new therapies by controlling stem cell differentiation.
Researchers have developed a new approach to treat ischemic pathologies by activating the protein HIF, which stimulates revascularization and organ repair. This strategy aims to address cardiovascular diseases that cause millions of deaths worldwide, by over-producing HIF in response to ischemia.
Researchers have developed a new leukemia therapy targeting cancer stem cells that drive acute myeloid leukemia (AML) growth. The antibody therapy, which specifically targets the CD123 protein, has shown promising results in laboratory models and clinical trials.
Researchers have discovered a molecular tool that selectively attacks human cancer cells, showing promise in treating human acute myeloid leukemia. The therapeutic approach exploits the high expression of CD123 on leukemia stem cells, targeting these critical cells to improve survival rates.
A study published by UCSF researchers found that bone marrow extract is as effective as bone marrow stem cells in improving cardiac function, decreasing scar tissue, and pumping capacity after a heart attack. Both therapies resulted in increased blood vessels and reduced cardiac cell death, showing promise for new treatments.
Allogeneic stem cell transplantation provides significant overall and relapse-free survival benefits for adult patients with intermediate- and poor-risk acute myeloid leukemia in first complete remission. However, its benefit varies by cytogenetic risk, with no significant advantage for good-risk AML.
Researchers at the Ottawa Hospital Research Institute have discovered a protein called Wnt7a that increases satellite stem cells in muscle tissue, leading to accelerated growth and repair. This breakthrough may lead to new therapeutic treatments for muscular diseases such as muscular dystrophy and sarcopenia.
Researchers demonstrated a non-invasive procedure that increased myocytes and reduced cardiac tissue injury by 60%, improving heart function by 40%. The therapy also reduced fibrosis, promoting regeneration of heart tissue.
Researchers discuss a combined approach to maximize the benefits of stem cell therapy while minimizing risks. Gene therapy has the potential to solve the problem of wayward stem cells wreaking havoc after transplantation by genetically modifying them prior to use.
The American Society for Neural Therapy and Repair (ASNTR) endorses the new NIH Guidelines, enabling research on human embryonic stem cells derived from IVF embryos. This move aims to facilitate the development of stem cell therapies for central nervous system diseases by reducing restrictions on cell line acquisition.
Researchers at Scripps Research Institute successfully generate embryonic-like stem cells from adult cells using chemical programming, overcoming safety concerns associated with genetic manipulation. This breakthrough has the potential to revolutionize personalized stem cell-based medicine for various diseases.
Researchers have found that human foetal stem cells can effectively treat back leg ischaemic ulcers in a model of type 1 diabetes. The culture mimics the wound-healing ability of the cells, suggesting they could be used as a 'factory' of wound-healing substances.
The University of Nottingham's studies found that improved collaboration with clinicians, better funding, and regulatory certainty are crucial for stem cell therapy success. The industry is at risk of market failure due to structural barriers within the NHS.
A new dual therapy approach generates new blood vessels and improves cardiac function following a heart attack, overcoming current stem-cell-mobilizing therapies' ineffectiveness in humans. This strategy stabilizes SDF-1 and enhances the recruitment of EPCs to damaged heart tissue.
Research at University of Gothenburg reveals that egg cells can rejuvenate sperm by extending telomeres, reducing the risk of chromosomal abnormalities. This breakthrough has significant implications for future stem cell therapy, which aims to replace diseased or dying cells.
Researchers found significant benefits in glycemic control and reduced insulin requirements in patients with type 2 diabetes who received stem cell infusion and hyperbaric oxygen treatment. The combination therapy showed promising results in decreasing type 2 diabetes morbidity and mortality.
Researchers have successfully tracked and confirmed the survival of stem cells in the body using a firefly-like bioluminescence imaging agent. This innovative technique enables precise targeting of stem cell delivery to specific blood vessels, opening new hope for treating peripheral arterial disease.
A rare case of a boy with Ataxia Telangiectasia developed abnormal growths in his brain and spinal cord four years after receiving human fetal stem cell therapy. The tumors were found to be benign neural tumors that could not have arisen from the patient's own tissues, highlighting the need for caution in stem cell therapy.
A genome-wide expression analysis identified 3,005 differentially expressed genes, including a ribosome and T-cell receptor signaling pathway. The study provides critical insight into the differences between leukemic stem cells and normal blood stem cells, potentially leading to targeted therapies.
A new study found that animal oocytes cannot fully reprogram adult human cells, making them unsuitable substitutes for producing patient-specific stem cells. The researchers tested using oocytes from cows, rabbits, and humans, but failed to achieve the necessary gene expression changes.
Researchers have effectively repaired damaged heart muscle using a novel population of stem cells derived from human skeletal muscle tissue. The transplanted myoendothelial cells improved heart function and reduced scar tissue, showing promise for regenerative medicine therapies.
Researchers found that direct implantation of mesenchymal stem cells did not remyelinate the damaged area, but still consider MSCs a promising tool for neurological disorders due to their pre-clinical efficacy in treating stroke and MS.
Researchers at Yerkes National Primate Research Center discovered dental pulp stem cells can stimulate growth of neural cells, showing therapeutic potential for diseases like Huntington's and Parkinson's. The study suggests dental pulp stem cells may be used in cell therapy and regenerative medicine.
A new study reveals that therapy targeting cyclin D1 can block the expansion of breast cancer cells, which are involved in therapy resistance and tumor recurrence. The findings provide a potential new treatment approach for targeted therapies at cancer stem cells in humans.
Researchers have found a way to restore key surface proteins in adult stem cells, enhancing their movement and therapeutic potential. The simple chemical procedure uses a molecule called SLeX to get the cells off the 'couch' and over to their therapeutic target.
Researchers at University of Bristol discover how bodies respond to internal distress signals, revealing potential for targeted stem cell therapy in heart patients. Kinin-sensitive EPCs identified as key to repairing blood supply and improving outcomes.
Researchers have developed a drug-inducible system to generate human induced pluripotent stem (iPS) cells with high efficiency. The new method requires less time than previous approaches and shows promise for development of cell therapies.
Researchers have developed a novel imaging approach using fluorocarbon labeling to visualize cell populations of interest in living bodies. This technology enables non-invasive location, tracking, and counting of specific immune cells, aiding cancer research and treatment.
The University of Georgia has been awarded a $9.2 million grant to explore the molecular underpinnings of human embryonic stem cell differentiation, aiming to identify genetic and protein modification patterns that accompany this process.
Researchers at the University of Florida have identified a molecular signature based on gene expression that can predict the development of acute graft-versus-host disease (GVHD) in patients receiving liver stem cell transplants. This could lead to better biomarkers for determining patient risk and improving treatment outcomes.
Researchers found that transplanted bone marrow stromal cells can differentiate into liver cells and may be used for cell replacement therapy. The study also suggests that these cells are not the origin of liver cancer in mice.
A study led by Beth Israel Deaconess Medical Center finds that a tumor suppressor protein called PML enables leukemia-initiating cells to maintain quiescence, making them resistant to conventional therapies. Inhibiting PML with an arsenic-based agent successfully treats chronic myeloid leukemia when combined with chemotherapy.
The UCI Sue and Bill Gross Stem Cell Research Center will house up to 26 researchers, a master's program in biotechnology, and programs educating patients and the public. The facility is expected to advance stem cell therapies for treating spinal cord injuries and other diseases.
A new study by UC Davis researchers provides evidence that methods using human bone marrow-derived stem cells to deliver gene therapy do not cause the development of tumors or leukemia. The study tested the safety of gene transfer into bone marrow stem cells in over 600 mice, with none developing leukemia or solid tumors.
StemCyte's move to New Jersey is driven by collaboration with Rutgers and a desire for proximity to groundbreaking research. The company will house its executive management and therapeutics team at the new office, which will support its northeast US operations.
Researchers are exploring the potential of generating insulin-producing cells using adult stem cells to treat type 1 diabetes. The partnership aims to restore normal blood sugar levels through autologous cell transplantation, eliminating the need for immunosuppressive agents.
Researchers are exploring optimal dosage and timing for stem cell therapy in adults with strokes and newborns with ischemic injuries. Pilot studies indicate a 25% improvement in recovery, leading to plans for clinical trials within two years.
Researchers found that human mesenchymal stem cells (hMSCs) and bone marrow stromal cells (BMSCs) can migrate to damaged brain tissue after a stroke, improving neural function. The transplanted cells may also enhance tissue repair and functional recovery.